These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 31804702)
1. Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke. Fiedorowicz A; Kozak-Sykała A; Bobak Ł; Kałas W; Strządała L Neurol Neurochir Pol; 2019; 53(6):484-491. PubMed ID: 31804702 [TBL] [Abstract][Full Text] [Related]
2. Sphingolipid changes in mouse brain and plasma after mild traumatic brain injury at the acute phases. Mondal K; Del Mar NA; Gary AA; Grambergs RC; Yousuf M; Tahia F; Stephenson B; Stephenson DJ; Chalfant CE; Reiner A; Mandal N Lipids Health Dis; 2024 Jun; 23(1):200. PubMed ID: 38937745 [TBL] [Abstract][Full Text] [Related]
3. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients. Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386 [TBL] [Abstract][Full Text] [Related]
4. Diverse Sphingolipid Profiles in Rectal and Colon Cancer. Markowski AR; Błachnio-Zabielska AU; Pogodzińska K; Markowska AJ; Zabielski P Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446046 [TBL] [Abstract][Full Text] [Related]
5. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients. Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071 [TBL] [Abstract][Full Text] [Related]
6. Differences in plasma levels of long chain and very long chain ceramides between African Americans and whites: An observational study. Buie JNJ; Hammad SM; Nietert PJ; Magwood G; Adams RJ; Bonilha L; Sims-Robinson C PLoS One; 2019; 14(5):e0216213. PubMed ID: 31067249 [TBL] [Abstract][Full Text] [Related]
8. Structural requirements of ceramide and sphingosine based inhibitors of mitochondrial ceramidase. Usta J; El Bawab S; Roddy P; Szulc ZM; Yusuf ; Hannun A; Bielawska A Biochemistry; 2001 Aug; 40(32):9657-68. PubMed ID: 11583166 [TBL] [Abstract][Full Text] [Related]
9. Regulation by sphingolipids of the fate of FRTL-5 cells. Satoh Y; Li X; Yokota H; Osada M; Ozaki Y; Katoh R; Yatomi Y J Biochem; 2009 Jan; 145(1):31-6. PubMed ID: 18953023 [TBL] [Abstract][Full Text] [Related]
10. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Kihara A; Mitsutake S; Mizutani Y; Igarashi Y Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104 [TBL] [Abstract][Full Text] [Related]
11. Intestinal absorption of sphingosine: new insights on generated ceramide species using stable isotope tracing in vitro. Calzada C; Cheillan D; Ritsch N; Vors C; Durand A; Pesenti S; Pettazzoni M; Meugnier E; Michalski MC; Penhoat A J Lipid Res; 2024 Jun; 65(6):100557. PubMed ID: 38719152 [TBL] [Abstract][Full Text] [Related]
12. Investigating sphingolipids as biomarkers for the outcomes of acute ischemic stroke patients receiving endovascular treatment. Lee TH; Cheng CN; Lee CW; Kuo CH; Tang SC; Jeng JS J Formos Med Assoc; 2023 Jan; 122(1):19-28. PubMed ID: 36184387 [TBL] [Abstract][Full Text] [Related]
13. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus. Patyna S; Büttner S; Eckes T; Obermüller N; Bartel C; Braner A; Trautmann S; Thomas D; Geiger H; Pfeilschifter J; Koch A Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106348. PubMed ID: 31301404 [TBL] [Abstract][Full Text] [Related]
14. Sphingolipidomic profile and HDL subfractions in obese dyslipidemic type 2 diabetic patients. Aslan İ; Aydın D; Koca Y; Yılmaz Ç; Çeker T; Öztüzün A; Aslan M Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106719. PubMed ID: 36863606 [TBL] [Abstract][Full Text] [Related]